Uptake of medicines for type 2 diabetes mellitus

15 June 2021 - Empagliflozin (with and without metformin hydrochloride) has been funded since 1 February 2021. It is funded for ...

Read more →

EU regulators develop recommendations to forecast demand of medicines

3 June 2021 - The EU Executive Steering Group on Shortages of Medicines Caused by Major Events has adopted a ...

Read more →

Sandoz Canada congratulates the Quebec government on implementing a shift towards biosimilars

18 May 2021 - The shift announced by Quebec will follow a similar approach to policies introduced in British Columbia, Alberta ...

Read more →

Almost one-third of adult Australians say they’re unlikely to get COVID vaccination: survey

19 May 2021 - Almost one-third of adult Australians say they are unlikely to be vaccinated against COVID-19 in a ...

Read more →

One in four COVID vaccine doses distributed in Australia not yet administered, figures show

17 May 2021 - New figures show one in four COVID-19 vaccines available in Australia have not been administered, with GP ...

Read more →

CMS expanding efforts to grow COVID-19 vaccine confidence and uptake amongst nation’s most vulnerable

11 May 2021 - CMS builds on whole of Government COVID-19 response with vaccination education, offering and reporting. ...

Read more →

Alberta, Canada, begins mandating switches from originator to biosimilar Humira

6 May 2021 - Alberta, Canada becomes the latest province to begin switching patients from originator adalimumab (Humira) to biosimilar ...

Read more →

Australia has surpassed 2 million vaccines but lacks data on second doses

28 April 2021 - Australians will not be told how many people have received a second dose of the COVID-19 vaccine ...

Read more →

Doctors stop offering AstraZeneca jabs over legal risk

11 April 2021 - Many of the nation’s GPs are refusing to offer AstraZeneca’s vaccine to people under 50 until ...

Read more →

Increasingly, Europeans do not trust AstraZeneca’s vaccine

22 March 2021 - Hesitancy could put the continent’s exit strategy from the pandemic at risk. ...

Read more →

Drug Utilisation Sub-Committee outcome statement

18 March 2021 - The outcome statement from the February 2021 Drug Utilisation Sub-Committee meeting is now available. ...

Read more →

Drug Utilisation SubCommittee utilisation analysis public release documents

18 March 2021 - The utilisation analysis public release documents from the October 2020 Drug Utilisation SubCommittee meeting are now available. ...

Read more →

Once again, the viability of the U.S. biosimilar market is thrown into question

15 March 2021 - Despite periodic reports that biosimilars have finally arrived and will save the U.S. health care system ...

Read more →

Pfizer COVID vaccine: states agree to secrecy over unused jabs

10 March 2021 - Australian states and territories have made a secret agreement not to release weekly data to the public ...

Read more →

Biosimilars: is interchangeability the proof of the pudding?

15 February 2021 - While apparently non‐inferior to originator biologics, other factors need to be considered before switching ...

Read more →